The effects of estrogen receptor activation are dependent on the dosage of its cognate gene [67] suggesting that the tumor promotion seen with resveratrol in Sirt1Y/+ animals may be a result of SIRT1 dosage-dependent modulation of estrogen receptor signalling. Here, ESR1 is linked to neoplasm.